Serum carbohydrate deficient transferrin as a sensitive marker in diagnosing alcohol abuse: A case - Control study

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 2, 2013, Pages 197-200

  Madhubala, V ^a   Subhashree, A R ^b   Shanthi, B ^b  

^a ESI hospital and PGIMSR   (India)

^b SREE BALAJI MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

CDT; Alcohol abuse; Diagnostic marker; GGT

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDERS IDENTIFICATION TEST QUESTIONNAIRE; ALCOHOLISM; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ANALYZER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CARBOHYDRATE DEFICIENT TRANSFERRIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MALE; MEAN CORPUSCULAR VOLUME; OUTPATIENT DEPARTMENT; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; TURBIDIMETRY;

EID: 84873648189     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5137.2726     Document Type: Article

References (22)

1. Source: H. K. Sharma, National Drug Dependence Treatment Centre AIIMS, New Delhi, 2003 (statistics).
2. Ray R, Mandal AB, Gupta K, Chatterjee A, Bajaji P. 2004. The Extent, Pattern and Trends of Drug Abuse in India: National Survey New Delhi: United Nations Office in Drugs and Crimes and Ministry of Social Jus-tice and Empowerment, Government of India.
3. Schuckit MA. Why don't we diagnose alcoholism in our patients? J Fam Pract. 1987; 25: 225-26.
4. Bradley KA, Debenedetti AF, Volk RJ, Williams EC, Frank D, KivlahanDR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007;31:1208-17.
5. Peter C Sharpe. Biochemical detection and monitoring of alcohol abuse and abstinence. Annals of Clinical Biochemistry. 2001;38:652-64.
6. Helander A. Biological markers in alcoholism. J Neura Transm Suppl 2003; 66: 15-32.
7. Reynaud M, Hourcade F, Planche F, Albuisson E, Meunier MN, Planche R; Usefulness of Carbohydrate deficient Transferrin in Alcoholic pa-tients with normal γ Glutamyl transpeptidase. Alcohol Clinical & ex-perimental Research. 1998; 22(3);615-18.
8. Allen JP, Sillanaukee P, Anton R. Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism. Alcohol Clin Exp Res 1999; 23: 115-20.
9. Torsten Arndt. Carbohydrate-deficient Transferrin as a marker of chronic alcohol abuse: A critical review of pre analysis, analysis and interpretation. Clinical Chemistry. 2001; 47(1); 13-27
10. De Feo TM, Fargion S, Duca L, Mattioci M, Chappellini MD, Sampietro M. Carbohydrate Deficient Transferrin, a sensitive marker of Chronic alcohol abuse, is highly influenced by body iron. Hepatology. 1999; 29: 658-63.
11. Idun. Marette, Mikkelsen, Rolf-Dieterkanity, Odd Nilssen, Nils Erik Huseby. CDT: Marker of actual alcohol consumption or Chronic alco-hol misuse? Alcohol & Alcoholism. 1998;33(6);646-50.
12. American Psychiatric Association. Diagnostic and statistical manual manual of mental disorders, (4th edition), text revision. Washington DC:American Psychiatric Association, 2000.
13. Stibler H. Carbohydrate-deficient transferrin in serum: a new mark-er of potentially harmful alcohol consumption reviewed. Clin Chem 1991;37: 2029-37.
14. Stibler H, Borg S, Joustra M. Micro anion exchange chromatogra-phy of carbohydrate-deficient transferrin in serum in relation to alco-hol consumption (Swedish patent 8400585-5). Alcohol Clin Exp Res 1986;10: 535-44.
15. Saunders JB, Aasland OG, Babor TF et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption -II. Addiction 1993, 88: 791-803.
16. Royal College of Physicians. A Great and Growing Evil ± The Medical Consequences of Alcohol Abuse. Report of a Working Party. London: Tavistock, 1987.
17. Bio-rad. Instruction manual for %CDT TIA. USA: Bio-rad, 2002; 1-32.
18. Martensson O, Harlin A, Brandt R, Seppa K, Sillanaukee P. Transferrin isorform distribution: Gender and alcohol consumption. Alcohol Clin. Exp. Res. 1997;21 (9);1710-15.
19. Aithal PG, Thornes H, Dwarakanath AD, Tanner A R. Measurement of CDT in a general medical clinic: Is this test useful in assessing alcohol consumption? Alcohol & Alcoholism; 1998; 33 (3); 304-09.
20. Anton RF, Dominick C, Bigelo M, West C, in collaboration with CDTect Research Group; Comparison of BioRad % CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationship with γ Glutamyl Transferase. Clinical Chemistry; 2001. 47:10;1769-75.
21. Hackler R, Arndt T, Helwig-Rolig A, kropf J, Steinmetz A, Schaefer JR. Investigation by iso electric focusing of the initial CDT and Non CDT transferrin isoform fractionation step involved in determination of CDT by the chron Alcohol. D. Assay. Clinical Chemistry; 2000;46:4; 483-92.
22. Salaspuro M (56) Research Unit of Alcohol Diseases, University of Helsinki, Finland. Carbohydrate deficient Transferrin as compared to other markers of Alcoholism: A systematic Review; Alcohol Vol. 19, No. 3 pp 261-271, 1999.